Search research articles
Contact Us
Filters
Showing results (361-370 of 400) with videos related to
Page
of 40
Sort By:
Mabs
|
September 26, 2024
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
Joanna Zikos, Gabriela M Webb, Helen L Wu, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
Iscience
|
June 23, 2025
Distinct transcriptomic signatures in pulmonary tissue resident and vascular resident-like T cells in nonhuman primates
Alexandra Melton, E Lake Potter, Toni Penney, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
Xenotransplantation
|
September 20, 2022
Genetic modifications designed for xenotransplantation attenuate sialoadhesin-dependent binding of human erythrocytes to porcine macrophages
Kaitlyn Petitpas, Zahra Habibabady, Veronica Ritchie, et al.
The Pharmacogenomics Journal
|
March 2, 2016
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
F Graziano, A Ruzzo, E Giacomini, et al.
Mbio
|
July 4, 2019
Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
Byoung-Shik Shim, Young-Chan Kwon, Michael J Ricciardi, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
British Journal of Cancer
|
July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F Loupakis, A Ruzzo, C Cremolini, et al.
Frontiers in Immunology
|
April 2, 2021
Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
Nuria Pedreño-Lopez, Brandon C Rosen, Walter J Flores, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 400) with videos related to
Sort By:
Page
of 40
Mabs
|
September 26, 2024
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
Joanna Zikos, Gabriela M Webb, Helen L Wu, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
Iscience
|
June 23, 2025
Distinct transcriptomic signatures in pulmonary tissue resident and vascular resident-like T cells in nonhuman primates
Alexandra Melton, E Lake Potter, Toni Penney, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
Xenotransplantation
|
September 20, 2022
Genetic modifications designed for xenotransplantation attenuate sialoadhesin-dependent binding of human erythrocytes to porcine macrophages
Kaitlyn Petitpas, Zahra Habibabady, Veronica Ritchie, et al.
The Pharmacogenomics Journal
|
March 2, 2016
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
F Graziano, A Ruzzo, E Giacomini, et al.
Mbio
|
July 4, 2019
Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
Byoung-Shik Shim, Young-Chan Kwon, Michael J Ricciardi, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
British Journal of Cancer
|
July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F Loupakis, A Ruzzo, C Cremolini, et al.
Frontiers in Immunology
|
April 2, 2021
Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
Nuria Pedreño-Lopez, Brandon C Rosen, Walter J Flores, et al.
Page
of 40